Silverfin false false 30/11/2025 30/11/2025 01/12/2024 no description of principal activity Christopher John Gerard Kelly 03/11/2015 SC519405 2025-11-30 SC519405 bus:Director1 2025-11-30 SC519405 2024-11-30 SC519405 core:CurrentFinancialInstruments 2025-11-30 SC519405 core:CurrentFinancialInstruments 2024-11-30 SC519405 2024-12-01 2025-11-30 SC519405 bus:Micro-entities 2024-12-01 2025-11-30 SC519405 bus:FilletedAccounts 2024-12-01 2025-11-30 SC519405 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 SC519405 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 SC519405 bus:Director1 2024-12-01 2025-11-30 SC519405 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure

Company No: SC519405 (Scotland)

# CALIA MEDICAL LIMITED

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH THE REGISTRAR

CALIA MEDICAL LIMITED

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025

Contents

CALIA MEDICAL LIMITED

## COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025
CALIA MEDICAL LIMITED

## COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025

DIRECTOR | Christopher John Gerard Kelly

SECRETARY | Aileen Isobel Kelly

REGISTERED OFFICE | 9 Chalton Road
| Bridge Of Allan
| Stirling
| FK9 4DX
| Scotland
| United Kingdom

COMPANY NUMBER | SC519405 (Scotland)

CHARTERED ACCOUNTANTS | Johnston Carmichael LLP
| 15 Academy Street
| Forfar
| DD8 2HA

CALIA MEDICAL LIMITED

## BALANCE SHEET

AS AT 30 NOVEMBER 2025
CALIA MEDICAL LIMITED

## BALANCE SHEET (continued)

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025

|  | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  | 31,029 |  | 13,096
Current assets |  | 39,301 |  | 35,327
Creditors: amounts falling due within one year |  | ( 50,497) |  | ( 38,719)
Net current liabilities |  | ( 11,196) |  | ( 3,392)
Total assets less current liabilities |  | 19,833 |  | 9,704
Net assets |  | 19,833 |  | 9,704
Capital and reserves |  | 19,833 |  | 9,704

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of CALIA Medical Limited (registered number: SC519405) were approved and authorised for issue by the director on 11 May 2026 and were signed on its behalf by:

Christopher John Gerard Kelly Director |

CALIA MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025
CALIA MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the FOR THE FINANCIAL YEAR ENDED 30 NOVEMBER 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC519405). The address of its registered office is 9 Chalton Road, Bridge Of Allan, Stirling, FK9 4DX, Scotland, United Kingdom.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including the director | 1 |  | 1

#### 3. Directors’ benefits: advances, credit and guarantees

##### Advances

During the period the company made advances to the director totalling £7,216 and £19,131 was introduced by the director. At 30 November 2025 the company owed the director £42,378 (2024 - £30,463). The loan is interest free, unsecured and has no fixed repayment terms.